TRIGLIMISAVE 1 MG (Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg))

Triglimisave 1 mg Tablet SR is a pharmaceutical formulation combining several active ingredients aimed at regulating glucose levels in the blood. This medication is particularly beneficial for adults diagnosed with type 2 diabetes mellitus and is typically prescribed alongside a balanced diet and an active lifestyle to enhance glycemic control. By facilitating the effective use of insulin in the body, Triglimisave aids in reducing elevated blood sugar levels. It is critical to adhere to the prescribed dosage and duration as instructed by a healthcare professional. Taking the tablet with food is necessary to mitigate any potential gastrointestinal discomfort. In cases where a dose is missed, it is advisable to take it promptly unless it is nearing the next scheduled dose; in such instances, the missed dose should be skipped to maintain the regular dosing regimen, avoiding any double dosing which could lead to adverse effects like hypoglycemia. Individuals may experience a drop in blood sugar, particularly when taking this medication with other antidiabetic agents, consuming alcohol, or missing meals. Regular monitoring of blood glucose levels is essential while on this treatment. Side effects can include gastrointestinal issues, headaches, and respiratory infections among others. Prior to commencing this medication, it is essential to disclose any pre-existing conditions, including kidney, liver, or cardiac issues, to your healthcare provider. Pregnant or nursing individuals should discuss their options with a healthcare professional before initiating therapy. Regular kidney function testing may be warranted during treatment.